PACB — Pacific Biosciences of California Share News
0.000.00%
Last trade - 00:00- $609.23m
- $1.02bn
- $160.01m
Brief: Pacbio Begins Commercialization Of The Onso Short-Read Sequencing System
Pacific Biosciences of California Inc reports results for the quarter ended in June - Earnings Summary
Brief: Pacific Biosciences of California Q2 Adjusted EPS USD -0.26 Vs. IBES Estimate USD -0.32
Pacific Biosciences of California Inc expected to post a loss of 32 cents a share - Earnings Preview
Brief: PacBio Announces Private Convertible Exchange Transaction Of $441 Mln Principal Amount Of 1.375% Convertible Senior Notes Due 2030
U.S. RESEARCH ROUNDUP-Apple, Estee Lauder Companies, SentinelOne
Brief: Pacbio Announces The Appointment Of Olga Troyanskaya From Princeton University To The Scientific Advisory Board
Pacific Biosciences of California Inc reports results for the quarter ended in March - Earnings Summary
Brief: Pacbio Reports First Quarter 2023 Results
Brief: Pacific Biosciences of California posts Q1 EPS of USD -0.36
Pacific Biosciences of California Inc expected to post a loss of 33 cents a share - Earnings Preview
Brief: Pacbio To Begin Commercial Shipment Of Revio Systems
Brief: Pacbio Announces Fourth Quarter And Fiscal Year 2022 Financial Results
Pacific Biosciences of California Inc reports results for the quarter ended in December - Earnings Summary
Pacific Biosciences of California Inc expected to post a loss of 36 cents a share - Earnings Preview
Brief: PacBio To Expand MAS-Seq Technology To 16S rRNA And Bulk RNA-Seq Solutions
U.S. STOCKS ON THE MOVE-Hess Corp, Monro, MarketAxess
U.S. STOCKS ON THE MOVE-Block Inc, Fennec, Inhibikase Therapeutics
U.S. STOCKS ON THE MOVE-Canoo, Microsoft, Boeing